FLUORODROP
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

FLUORODROP Trademark

Serial Number: 79297555 • Registration: 6854447

FLUORODROP is a trademark filed by FRAUNHOFER-GESELLSCHAFT zur Förderung der angewandten Forschung e.V. on September 23, 2020. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

FRAUNHOFER-GESELLSCHAFT zur Förderung der angewandten Forschung e.V. (116 trademarks)

Hansastraße 27c

Entity Type: 98

Trademark Details

Filing Date

September 23, 2020

Registration Date

September 27, 2022

Published for Opposition

July 12, 2022

Goods & Services

Organisation, arranging and conducting of courses, seminars, workshops, symposiums, con-gresses and conferences in the field of biotechnology, molecular biology, cell biology, mi-crobiology, immunology, genetics and medical research; Organisation, arranging and con-ducting of courses, seminars and workshops, in the field of training for handling scientific instruments and apparatus for research in laboratories

Scientific apparatus and instruments, namely, laboratory apparatus and instruments for analyzing highly diluted fluorescence signals in nucleic acid solutions, micelle solutions, plasmid solutions or protein solutions; scientific apparatus and instruments, namely, electronic and optical apparatus in form of a plate reader, for analysis of highly diluted fluorescence signals in nucleic acid solutions, micelle solutions, plasmid solutions or protein solutions; testing apparatus not for medical purposes for analyzing the concentration, size and molarity of fluorescently labeled or fluorescent molecules, in particular labeled nucleic acids; downloadable and recorded computer software for live view of measurements in nucleic acid solutions, micelle solutions, plasmid solutions or protein solutions in the form of fluorescence traces and correlation curves, result presentation per sample, and save/load capabilities for measurements; parts of the aforesaid goods, namely, sample holders for laboratory apparatus and instruments for analyzing highly diluted fluorescence signals in nucleic acid solutions, micelle solutions, plasmid solutions or protein solutions

Conducting medical and clinical medical practice examinations

Analysis devices and diagnostic apparatus for medical purposes, namely, medical apparatus for high-precision nucleic acid analysis for biomarker detection in the field of oncology or immunology and for sequence specific detection of viral components in the field of point-of-care or laboratory diagnosis; parts for all the aforesaid goods, namely, disposable probe holders for medical apparatus for high-precision nucleic acid analysis for biomarker detection in the field of oncology or immunology and for sequence specific detection of viral components in the context of point-of-care or laboratory diagnosis

Scientific and technological services, namely, research and design in the field of biotechnology, molecular biology, cell biology, microbiology, immunology and genetics; scientific and industrial research in the field of biotechnology, molecular biology, cell biology, microbiology, immunology and genetics; Testing, authentication and quality control for others, namely, testing of fluorescently labeled molecules or fluorescent molecules in terms of concentration, size and molarity; Testing, authentication and quality control for others, namely, testing of fluorescently labeled molecules or fluorescent molecules in terms of concentration, size and molarity in the field of health services, food and drink industry and chemical industry; development of measuring and testing methods for biology laboratory procedures; Technical measurement and analysis, namely, analysis of concentration, size and molarity of fluorescently labeled or fluorescent molecules, in particular labeled nucleic acids; Design and development of computer software; Medical laboratory services

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 6, 2023 FINO
GENERIC MADRID TRANSACTION SENT TO IB
Jan 17, 2023 XXSS
GENERIC MADRID TRANSACTION CREATED
Jan 17, 2023 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 27, 2022 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Sep 27, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Sep 27, 2022 R.PR
NOTIFICATION PROCESSED BY IB
Jul 18, 2022 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 12, 2022 NPUB
PUBLISHED FOR OPPOSITION
Jul 12, 2022 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 23, 2022 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jun 22, 2022 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 22, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 4, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 2, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 1, 2022 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jun 1, 2022 ERFR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
May 3, 2022 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 11, 2022 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Apr 6, 2022 OPNR
NOTIFICATION OF FINAL REFUSAL EMAILED
Dec 14, 2021 GNFN
FINAL REFUSAL E-MAILED
Dec 14, 2021 GNFR
FINAL REFUSAL WRITTEN
Dec 14, 2021 CNFR
ASSIGNED TO EXAMINER
Nov 16, 2021 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 19, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 18, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 18, 2021 TROA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Aug 18, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 18, 2021 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Aug 18, 2021 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 18, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 18, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Aug 18, 2021 COAR
REFUSAL PROCESSED BY IB
Mar 15, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 24, 2021 RFCS
REFUSAL PROCESSED BY MPU
Feb 24, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 19, 2021 RFCR
NON-FINAL ACTION WRITTEN
Feb 18, 2021 CNRT
ASSIGNED TO EXAMINER
Feb 11, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
Nov 13, 2020 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 9, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 5, 2020 REPR